CNBX Pharmaceuticals Inc. Quarterly Revenues in USD from Q1 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Revenues history and growth rate from Q1 2015 to Q4 2024.
  • CNBX Pharmaceuticals Inc. Revenues for the quarter ending November 30, 2024 was $0.000, a 100% decline year-over-year.
  • CNBX Pharmaceuticals Inc. Revenues for the twelve months ending November 30, 2024 was $40.6K, a 91.9% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Revenues for 2024 was $130K, a 68.3% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Revenues for 2023 was $410K, a 1269% increase from 2022.
  • CNBX Pharmaceuticals Inc. annual Revenues for 2022 was $30K.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $40.6K $0 -$89.4K -100% Sep 1, 2024 Nov 30, 2024 10-Q 2025-01-13
Q3 2024 $130K $0 -$100K -100% Jun 1, 2024 Aug 31, 2024 10-K 2024-11-29
Q2 2024 $230K $0 -$310K -100% Mar 1, 2024 May 31, 2024 10-Q 2024-07-15
Q1 2024 $540K $40.6K +$40.6K Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-16
Q4 2023 $500K $89.4K +$89.4K Sep 1, 2023 Nov 30, 2023 10-Q 2025-01-13
Q3 2023 $410K $100K Jun 1, 2023 Aug 31, 2023 10-K 2024-11-29
Q2 2023 $310K +$310K Mar 1, 2023 May 31, 2023 10-Q 2024-07-15
Q1 2023 $0 Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-16
Q4 2022 $0 Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-12
Q2 2022 $0 $0 Mar 1, 2022 May 31, 2022 10-Q 2023-07-14
Q3 2021 $0 $0 -$2.21K -100% Jun 1, 2021 Aug 31, 2021 10-K 2021-11-29
Q2 2021 $2.21K $0 -$1.89K -100% Mar 1, 2021 May 31, 2021 10-Q 2021-07-14
Q1 2021 $4.09K $0 -$1.31K -100% Dec 1, 2020 Feb 28, 2021 10-Q 2021-04-14
Q4 2020 $5.4K $0 -$1.75K -100% Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-14
Q3 2020 $7.16K $2.21K +$149 +7.24% Jun 1, 2020 Aug 31, 2020 10-K 2021-11-29
Q2 2020 $7.01K $1.89K -$274 -12.7% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 $7.28K $1.31K -$1.01K -43.5% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 $8.29K $1.75K -$1.55K -46.9% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 $9.84K $2.06K -$898 -30.4% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-04
Q2 2019 $10.7K $2.16K -$796 -26.9% Mar 1, 2019 May 31, 2019 10-Q 2020-07-14
Q1 2019 $11.5K $2.32K +$389 +20.1% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-13
Q4 2018 $11.1K $3.31K +$1.55K +88% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-14
Q3 2018 $9.6K $2.96K +$86.00 +3% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-29
Q2 2018 $9.52K $2.96K +$1.39K +88.2% Mar 1, 2018 May 31, 2018 10-Q 2019-07-15
Q1 2018 $8.13K $1.93K +$688 +55.4% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-15
Q4 2017 $7.44K $1.76K +$1.76K Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-17
Q3 2017 $5.68K $2.87K Jun 1, 2017 Aug 31, 2017 10-K 2018-11-29
Q2 2017 $1.57K -$48.4K -96.9% Mar 1, 2017 May 31, 2017 10-Q 2018-07-16
Q1 2017 $1.24K -$11.3K -90.1% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-05
Q4 2016 $0 Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-16
Q2 2016 $50K +$50K Mar 1, 2016 May 31, 2016 10-Q 2017-07-17
Q1 2016 $12.5K +$12.5K Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-14
Q2 2015 $0 Mar 1, 2015 May 31, 2015 10-Q 2016-07-13
Q1 2015 $0 Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.